Blog
RSS FeedPosted by Michael Wonder on 03 Aug 2017
Sandoz Erelzi (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases
2 August 2017 - Positive recommendation moves Erelzi closer to federal, provincial and territorial drug plan reimbursement. ...
Posted by Michael Wonder on 01 Aug 2017
Sharing patient input submissions for the CDR program
1 August 2017 - Since February 2014, CADTH has shared patient input submissions on our website, when permission has been ...
Posted by Michael Wonder on 01 Aug 2017
Proposed revisions to CADTH’s biosimilar review process
1 August 2017 - Given the type of data required to support biosimilar authorization differs from that required for a biologic ...
Posted by Michael Wonder on 17 Jul 2017
Quebec expects $1.2 billion in savings with new drug price deal
17 July 2017 - Government and generic-drug makers cap weeks of tense talks. ...
Posted by Michael Wonder on 13 Jul 2017
Proposed revision to the procedure for the CADTH Common Drug Review and the CADTH Therapeutic Review Framework
13 July 2017 - CADTH is inviting stakeholder comments and feedback on proposed revisions to the Procedure for the CADTH Common ...
Posted by Michael Wonder on 06 Jul 2017
Changes could reduce access to medications
6 July 2017 - In a speech in May, federal Health Minister Jane Philpott talked about rising prescription drug prices ...
Posted by Michael Wonder on 03 Jul 2017
Supreme Court hands patent win to pharmaceutical companies
30 June 2017 - Canada’s Supreme Court on Friday struck down rules making it easy for generic drug firms to ...
Posted by Michael Wonder on 28 Jun 2017
Quebec expects to save millions with overhaul of generic-drug purchasing process
28 June 2017 - Quebec is launching an attempt to save millions in drug costs through an overhaul of the ...
Posted by Michael Wonder on 23 Jun 2017
Provinces lead the way towards pharmacare in Canada
24 June 2017 - Canada is the only country in the world that has a universal health care system that does ...
Posted by Michael Wonder on 13 Jun 2017
Integrating companion diagnostics into CDR and pCODR reviews
13 June 2017 - In November 2016, CADTH invited stakeholder comments and feedback on a proposed process for the assessment ...
Posted by Michael Wonder on 12 Jun 2017
Canada pays more for prescription drugs for common conditions than other wealthy countries: CMAJ study
12 June 2017 - Canada had second highest costs when compared to nine other affluent countries with universal health care. ...
Posted by Michael Wonder on 11 Jun 2017
Subsequent entry products for non-biological complex drugs
9 June 2017 - In order to reflect the current environment for subsequent entry non-biological complex drugs, CADTH, in consultation ...
Posted by Michael Wonder on 29 May 2017
CADTH publishes final recommendations for two Servier medicines
25 May 2017 - CADTH has published outcomes for edoxaban tosylate (Lixiana) and ivabradine hydrochloride (Lancora). ...
Posted by Michael Wonder on 27 May 2017
US drug prices are so high that Canada wants other countries as reference points
22 May 2017 - How high are drug prices in the US? So high that the Canadian government may remove ...
Posted by Michael Wonder on 25 May 2017
Earlier access to new drugs could solve Canada's affordability crisis
23 May 2017 - Policymakers are fiercely debating how to tackle the soaring costs of prescription drugs in Canada. ...